Pneumonia relevant to lung transplantation and pathogen distribution

Area of Science:

• Pulmonology
• Transplant Surgery
• Infectious Diseases

Background:

• Pneumonia is a leading cause of morbidity and mortality in lung transplant (LT) recipients.
• Understanding pneumonia's incidence, causes, and risk factors is crucial for improving outcomes in this vulnerable population.

Purpose of the Study:

• To evaluate the incidence, etiology, risk factors, and prognosis of pneumonia in lung transplant recipients.
• To identify common pathogens and risk factors associated with pneumonia post-transplantation.

Main Methods:

• Retrospective analysis of prospectively collected data from 28 lung transplant recipients.
• Data included demographics, transplant details, follow-up information, and patient status.
• Analysis focused on pneumonia episodes, causative agents, and associated risk factors.

Main Results:

• 22 of 28 LT recipients (79%) experienced 47 pneumonia episodes.
• Common pathogens included Pseudomonas aeruginosa (20%), cytomegalovirus (CMV) (15%), and Aspergillus fumigatus (10%).
• CMV pneumonia occurred in 25% of recipients, with bacterial and CMV infections being risk factors for Aspergillus infections. Pulmonary tuberculosis (TB) incidence was 18%, with prior TB history increasing relapse risk.

Conclusions:

• Pneumonia continues to be a major cause of morbidity and mortality in lung transplant recipients.
• Pseudomonas aeruginosa, CMV, and Aspergillus fumigatus are the most frequent infectious agents.
• Lung transplant recipients face a high risk of TB, and a history of TB is a risk factor for relapse.